With the recent FDA approval, Zolgensma became the world’s most expensive medication. Priced at $2.125 million per patient, the one-dose gene therapy is a potential life-saver for children with spinal muscular atrophy (SMA). Now, the treatment is at the center of an intensifying debate over the rising price of medications.

Industry watchdogs are outraged. They say Zolgensma is merely the latest example ...

Read more...

These are trying times for health care optimists. Despite all the hype surrounding breakthroughs in clinical practice and technology, American medicine is stuck in in neutral. Though the engine is revving loudly, little progress is being made. This unfortunate truth came into clearer light last week when I was preparing lesson plans for the health care strategy course I teach at the Stanford Graduate School of Business. During the first class of ...

Read more...

As first reported by The Wall Street Journal late last month, the war against anti-vaccination propaganda now has a new battlefront. Pinterest, the social-media platform where users discover images and information, has begun blocking vaccine-related search terms on its site. Anti-vaccine content contradicts evidence-based science and established research, the company told WSJ, while cautioning that the search ban is only 
Read more...

Imagine you’re a CEO in charge of a health care organization with thousands of physicians and 19 hospitals. Overall, the quality of care delivered is good. Prices and costs are low. But there is a problem: Patients rate your service below average. Making matters worse, a swarm of low-priced competitors have moved in, challenging your market share. You’re going to need to improve patient satisfaction to survive. What do you do? About ...

Read more...

Like prep sports or prime-time television, medical meetings have seasons. In the spring and fall, my calendar fills with invitations to speak. I try to get to the venue a few hours before I’m scheduled to speak, so I can “take the pulse” of fellow doctors, asking them about their practices, patients and the future of medicine. Figuratively speaking, the industry’s pulse is racing with fear. I’ve observed that in just the past ...

Read more...

While walking through the duty-free at Dulles International Airport in Washington, DC, I happened upon the price tag of an imported French purse. Looking around, I wondered how many travelers could afford a $2,000 handbag.At the gate, I found a seat and logged on to the internet, where I happened upon a story about the CEO of Nostrum Laboratories, Nirmal Mulye. In an interview, Mr. Mulye explained why he raised the ...

Read more...

Have you ever been the only customer in your local supermarket? Although the experience can be a bit unnerving, at first, you soon start to notice the advantages: No line at the deli, no pushy shoppers, no carts jamming up the produce section. As you breeze through checkout, you think to yourself, “Gee, I could get used to this.” Now, imagine walking into an empty waiting area at your local emergency ...

Read more...

When news broke that Dr. Atul Gawande had been named CEO of the Amazon-Berkshire-JPMorgan Chase health care partnership, industry insiders were quick to raise doubts about his credentials. Some pointed to his limited administrative experience, questioning how someone who has never managed a hospital or health system could oversee the care of some 1 million patient-employees. They also noted that the surgeon and bestselling author doesn’t know much ...

Read more...

About 30 miles east of LA, on the quiet tree-lined campus of Claremont Graduate University, sunlight pierces the ornately covered windows of a lower-level classroom in Harper Hall. A glow is cast upon the 25 students of Dr. Debbie Freund’s health policy course; PhD candidates and practicing physicians among them. Many of these bright young scholars will go on to take leadership roles in health policy, public health, IT and medical research. I ...

Read more...

Physicians have a love-hate relationship with the electronic health record (EHR). On the one hand, doctors know they can't provide the best possible medical care without them. And on the other, today's EHR systems are cumbersome, clunky and slow physicians down. Indeed, there's much to love and much to hate about today's EHRs, alongside a variety of ways to address the problems they create. One solution may lie in blockchain, the technology currently ...

Read more...

9 Pages

Most Popular

✓ Join 150,000+ subscribers 
✓ Get KevinMD's 5 most popular stories
Subscribe. It's free.